RAMUCIRUMAB

RAMUCIRUMAB was reported 6320 times

RAMUCIRUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INCARCERATED HIATUS HERNIA 2 0.2222
1 GASTROENTERITIS BACILLUS 2 0.1667
2 CARBOHYDRATE ANTIGEN 72-4 INCREASED 2 0.1667
3 TUMOUR CAVITATION 9 0.1636
4 OESOPHAGEAL ADENOCARCINOMA STAGE IV 3 0.1500
5 BLOOD THROMBOPLASTIN DECREASED 2 0.0833
6 TUMOUR PERFORATION 26 0.0818
7 HER2 POSITIVE GASTRIC CANCER 2 0.0625
8 ULCERATIVE GASTRITIS 7 0.0625
9 GASTROINTESTINAL STOMA NECROSIS 2 0.0526
10 ULCERATED HAEMANGIOMA 3 0.0492
11 UPPER GASTROINTESTINAL PERFORATION 3 0.0476
12 PYOGENIC GRANULOMA 22 0.0472
13 GLOMERULAR VASCULAR DISORDER 7 0.0467
14 OESOPHAGOBRONCHIAL FISTULA 7 0.0461
15 ISCHAEMIC ENTERITIS 4 0.0412
16 ADENOCARCINOMA METASTATIC 8 0.0388
17 HAEMANGIOMA OF BONE 7 0.0366
18 DRUG METABOLITE LEVEL HIGH 3 0.0357
19 IMMUNE-MEDIATED CYSTITIS 4 0.0348
20 LOWER GASTROINTESTINAL PERFORATION 2 0.0339
21 LICHEN PLANUS PEMPHIGOIDES 2 0.0333
22 METASTATIC GASTRIC CANCER 10 0.0291
23 COLONY STIMULATING FACTOR THERAPY 6 0.0290
24 TUMOUR HAEMORRHAGE 81 0.0284
25 DIAPHRAGMATIC RUPTURE 5 0.0279
26 BONE SEQUESTRUM 4 0.0263
27 PREALBUMIN DECREASED 3 0.0250
28 CHYLOTHORAX 18 0.0250
29 JEJUNAL PERFORATION 6 0.0249
30 PERFORATION 20 0.0248
31 OCULAR PEMPHIGOID 3 0.0240
32 THROMBOPHLEBITIS MIGRANS 8 0.0235
33 ANASTOMOTIC COMPLICATION 8 0.0233
34 GASTRIC CANCER RECURRENT 3 0.0231
35 STOMA SITE ULCER 4 0.0226
36 MUCOSAL TOXICITY 6 0.0221
37 HEPATIC ARTERY ANEURYSM 2 0.0208
38 ALPHA 1 FOETOPROTEIN ABNORMAL 2 0.0200
39 ENTEROCELE 2 0.0198
40 GASTRIC PERFORATION 53 0.0194
41 MUCOSAL NECROSIS 3 0.0191
42 GASTROINTESTINAL PERFORATION 78 0.0187
43 RADIATION MUCOSITIS 3 0.0186
44 HAEMANGIOMA OF SKIN 7 0.0161
45 LIVER CARCINOMA RUPTURED 4 0.0159
46 HEPATIC ATROPHY 7 0.0156
47 BILOMA 2 0.0142
48 ANASTOMOTIC ULCER HAEMORRHAGE 2 0.0140
49 FULMINANT TYPE 1 DIABETES MELLITUS 14 0.0136
50 ILEAL PERFORATION 9 0.0136
51 NEPHROTIC SYNDROME 90 0.0131
52 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 3 0.0130
53 PANCREATIC FISTULA 2 0.0130
54 LYMPHORRHOEA 2 0.0128
55 METASTASES TO OVARY 4 0.0125
56 OESOPHAGEAL CANCER METASTATIC 4 0.0125
57 MALIGNANT ASCITES 9 0.0117
58 INTESTINAL HAEMATOMA 2 0.0114
59 BILE ACIDS INCREASED 2 0.0113
60 HERPES ZOSTER MENINGOENCEPHALITIS 4 0.0111
61 BASILAR ARTERY THROMBOSIS 2 0.0111
62 NON-SMALL CELL LUNG CANCER STAGE IV 4 0.0110
63 CATHETER SITE THROMBOSIS 3 0.0109
64 BLOOD CHOLINESTERASE DECREASED 3 0.0109
65 GASTRIC STENOSIS 2 0.0109
66 RECALL PHENOMENON 9 0.0108
67 MYELOCYTE COUNT INCREASED 2 0.0107
68 SMALL INTESTINAL PERFORATION 20 0.0107
69 PUTAMEN HAEMORRHAGE 3 0.0105
70 OESOPHAGEAL ADENOCARCINOMA 5 0.0105
71 SPINAL EPIDURAL HAEMATOMA 6 0.0102
72 BRONCHIAL FISTULA 2 0.0099
73 BLADDER TAMPONADE 3 0.0099
74 NASAL HERPES 2 0.0099
75 ADRENOMEGALY 2 0.0096
76 POST PROCEDURAL BILE LEAK 3 0.0096
77 OESOPHAGEAL FISTULA 3 0.0094
78 VITAMIN B1 DEFICIENCY 4 0.0094
79 VARICOSE VEIN RUPTURED 3 0.0093
80 PSEUDOCIRRHOSIS 3 0.0090
81 RECTAL STENOSIS 3 0.0090
82 ANASTOMOTIC ULCER 4 0.0087
83 SUTURE RUPTURE 6 0.0087
84 ADENOCARCINOMA GASTRIC 8 0.0086
85 IMMUNE-MEDIATED PNEUMONITIS 2 0.0085
86 DIVERTICULITIS INTESTINAL PERFORATED 3 0.0084
87 OESOPHAGEAL PERFORATION 7 0.0084
88 METASTASES TO PERITONEUM 21 0.0083
89 DUODENAL PERFORATION 8 0.0081
90 MALIGNANT NEOPLASM PROGRESSION 817 0.0080
91 IMMUNE-MEDIATED HYPERTHYROIDISM 2 0.0079
92 TRACHEO-OESOPHAGEAL FISTULA 5 0.0078
93 GLOMERULONEPHROPATHY 2 0.0078
94 STAPHYLOCOCCAL ABSCESS 5 0.0078
95 CARBOHYDRATE ANTIGEN 19-9 INCREASED 4 0.0076
96 METASTASES TO MENINGES 17 0.0075
97 PROTEINURIA 142 0.0075
98 PNEUMOTHORAX SPONTANEOUS 5 0.0074
99 TUMOUR ASSOCIATED FEVER 3 0.0073
100 GASTROINTESTINAL ISCHAEMIA 2 0.0072
101 OESOPHAGEAL VARICES HAEMORRHAGE 15 0.0069
102 GASTROINTESTINAL FISTULA 6 0.0068
103 FIBRIN DEGRADATION PRODUCTS INCREASED 2 0.0068
104 GASTRIC FISTULA 3 0.0067
105 PULMONARY ARTERY THROMBOSIS 5 0.0065
106 GASTRITIS BACTERIAL 3 0.0064
107 BRONCHIAL HAEMORRHAGE 2 0.0064
108 INTERSTITIAL LUNG DISEASE 301 0.0062
109 NASAL SEPTUM PERFORATION 4 0.0062
110 ASCITES 181 0.0062
111 BLOOD CORTICOTROPHIN DECREASED 3 0.0061
112 SMALL INTESTINAL HAEMORRHAGE 12 0.0060
113 FEBRILE INFECTION 7 0.0059
114 LARGE INTESTINAL HAEMORRHAGE 13 0.0058
115 LYMPHANGIOSIS CARCINOMATOSA 6 0.0058
116 GASTROENTERITIS CLOSTRIDIAL 2 0.0057
117 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 5 0.0057
118 RETROPERITONEAL LYMPHADENOPATHY 3 0.0057
119 IMMUNE-MEDIATED HEPATIC DISORDER 11 0.0056
120 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 7 0.0056
121 ALPHA 1 FOETOPROTEIN INCREASED 4 0.0056
122 ALBUMINURIA 3 0.0056
123 IMMUNE-MEDIATED CHOLANGITIS 2 0.0056
124 GLOMERULONEPHRITIS PROLIFERATIVE 2 0.0055
125 PARONYCHIA 24 0.0055
126 DERMATITIS ACNEIFORM 33 0.0054
127 BRONCHOPLEURAL FISTULA 2 0.0053
128 MICROANGIOPATHY 5 0.0053
129 LACRIMAL STRUCTURE INJURY 2 0.0053
130 DIABETIC KETOSIS 2 0.0053
131 IMMUNE-MEDIATED PANCREATITIS 2 0.0052
132 IMMUNE-MEDIATED ARTHRITIS 2 0.0052
133 HYPOPITUITARISM 9 0.0052
134 CARCINOEMBRYONIC ANTIGEN INCREASED 10 0.0052
135 GASTROINTESTINAL ANASTOMOTIC LEAK 2 0.0051
136 LUNG CYST 2 0.0051
137 JUGULAR VEIN THROMBOSIS 9 0.0051
138 DISSEMINATED INTRAVASCULAR COAGULATION 70 0.0050
139 PERIPHERAL SENSORY NEUROPATHY 29 0.0050
140 ARTERY DISSECTION 2 0.0048
141 HAEMOBILIA 2 0.0048
142 OESOPHAGEAL RUPTURE 4 0.0048
143 PERIPHERAL ARTERY ANEURYSM 2 0.0047
144 NON-SMALL CELL LUNG CANCER METASTATIC 4 0.0046
145 PERITONITIS 94 0.0045
146 GASTROINTESTINAL OEDEMA 8 0.0045
147 DIVERTICULUM INTESTINAL HAEMORRHAGIC 10 0.0044
148 PARANEOPLASTIC SYNDROME 3 0.0044
149 PROTEIN URINE 4 0.0044
150 NEUTROPHIL COUNT DECREASED 179 0.0044
151 CORTISOL DECREASED 5 0.0044
152 DIVERTICULAR PERFORATION 9 0.0044
153 ANEURYSM RUPTURED 4 0.0044
154 METASTASES TO ADRENALS 4 0.0043
155 THYROIDITIS 13 0.0043
156 HAEMANGIOMA 10 0.0043
157 LARGE INTESTINE PERFORATION 30 0.0043
158 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 2 0.0043
159 EMBOLISM VENOUS 13 0.0043
160 MENINGISM 2 0.0043
161 RECTAL ULCER 5 0.0043
162 ALVEOLITIS 6 0.0042
163 JAUNDICE CHOLESTATIC 15 0.0042
164 PULMONARY TOXICITY 30 0.0042
165 BRAIN STEM HAEMORRHAGE 4 0.0042
166 CEREBELLAR HAEMORRHAGE 6 0.0042
167 MALIGNANT PLEURAL EFFUSION 7 0.0041
168 HYPOALBUMINAEMIA 32 0.0041
169 CEREBRAL ARTERY EMBOLISM 5 0.0041
170 PROTEIN-LOSING GASTROENTEROPATHY 2 0.0040
171 NECROTISING OESOPHAGITIS 2 0.0040
172 FEBRILE NEUTROPENIA 265 0.0040
173 DIABETIC RETINAL OEDEMA 2 0.0039
174 NOCTURNAL DYSPNOEA 5 0.0039
175 RENAL CANCER METASTATIC 3 0.0039
176 DACRYOSTENOSIS ACQUIRED 5 0.0039
177 ONYCHOLYSIS 6 0.0038
178 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 3 0.0038
179 TUMOUR NECROSIS 4 0.0038
180 BLEEDING VARICOSE VEIN 2 0.0037
181 HYPOPROTEINAEMIA 7 0.0037
182 TUMOUR PSEUDOPROGRESSION 4 0.0037
183 PNEUMONITIS 99 0.0036
184 AORTIC DISSECTION 15 0.0036
185 THROMBOTIC MICROANGIOPATHY 35 0.0036
186 POLYNEUROPATHY 43 0.0036
187 THERAPY PARTIAL RESPONDER 56 0.0036
188 INTESTINAL FISTULA 5 0.0035
189 NON-SMALL CELL LUNG CANCER 17 0.0035
190 IMMUNE-MEDIATED ENTEROCOLITIS 13 0.0035
191 HEPATIC HAEMORRHAGE 3 0.0035
192 PROTEIN URINE PRESENT 17 0.0034
193 PORTAL VEIN THROMBOSIS 11 0.0034
194 DIAPHRAGMATIC HERNIA 2 0.0032
195 HEPATOBILIARY DISEASE 2 0.0032
196 METASTASES TO LIVER 56 0.0032
197 PNEUMONIA CRYPTOCOCCAL 3 0.0032
198 GASTRIC NEOPLASM 2 0.0032
199 ADENOCARCINOMA 7 0.0031
200 ONCOLOGIC COMPLICATION 3 0.0031
201 GASTROINTESTINAL MUCOSAL DISORDER 2 0.0031
202 SPLENIC RUPTURE 5 0.0030
203 GENE MUTATION 6 0.0030
204 GASTROENTERITIS NOROVIRUS 4 0.0030
205 MESENTERIC VEIN THROMBOSIS 3 0.0030
206 VENA CAVA THROMBOSIS 5 0.0030
207 IMMUNE-MEDIATED DERMATITIS 3 0.0030
208 CHOLANGITIS 18 0.0029
209 NUTRITIONAL CONDITION ABNORMAL 2 0.0029
210 PELVIC FLUID COLLECTION 2 0.0028
211 OESOPHAGEAL STENOSIS 8 0.0028
212 HAEMOPTYSIS 78 0.0028
213 HEPATIC ENCEPHALOPATHY 26 0.0028
214 PERFORMANCE STATUS DECREASED 13 0.0028
215 DYSLALIA 2 0.0028
216 OESOPHAGEAL CANDIDIASIS 11 0.0028
217 CACHEXIA 14 0.0027
218 PNEUMOTHORAX 43 0.0027
219 PNEUMOPERITONEUM 5 0.0027
220 INTESTINAL PERFORATION 30 0.0027
221 LUNG ADENOCARCINOMA 8 0.0027
222 HAEMATOTOXICITY 25 0.0026
223 INFECTIOUS PLEURAL EFFUSION 4 0.0026
224 ARTERIAL HAEMORRHAGE 3 0.0026
225 DIFFUSE ALVEOLAR DAMAGE 3 0.0026
226 COLORECTAL CANCER METASTATIC 6 0.0025
227 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 2 0.0025
228 METASTASES TO LUNG 29 0.0025
229 EMBOLISM ARTERIAL 3 0.0025
230 LYMPHANGITIS 2 0.0025
231 ABDOMINAL ABSCESS 11 0.0025
232 CHRONIC HEPATITIS 2 0.0025
233 MONOCYTE COUNT DECREASED 3 0.0025
234 OSTEOLYSIS 5 0.0024
235 CHOLANGITIS SCLEROSING 5 0.0024
236 HYDROTHORAX 2 0.0024
237 EMBOLISM 20 0.0024
238 CULTURE POSITIVE 2 0.0024
239 LUNG ABSCESS 5 0.0024
240 ENTERITIS INFECTIOUS 4 0.0023
241 ILEUS 29 0.0023
242 PHYSICAL DECONDITIONING 6 0.0023
243 CARDIAC VENTRICULAR THROMBOSIS 3 0.0023
244 SERUM FERRITIN DECREASED 4 0.0023
245 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 22 0.0023
246 VASCULAR PSEUDOANEURYSM 4 0.0023
247 VENOUS THROMBOSIS 9 0.0023
248 TUMOUR MARKER INCREASED 11 0.0023
249 MYELOSUPPRESSION 82 0.0023
250 ILEUS PARALYTIC 10 0.0022
251 STRESS CARDIOMYOPATHY 13 0.0022
252 MUCOSAL INFLAMMATION 58 0.0022
253 MONOCYTE COUNT INCREASED 8 0.0022
254 IMMUNE-MEDIATED LUNG DISEASE 4 0.0022
255 ISCHAEMIC HEPATITIS 3 0.0022
256 ENTEROCOLITIS INFECTIOUS 2 0.0022
257 ANAL HAEMORRHAGE 6 0.0021
258 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0021
259 PERIPHERAL ARTERY THROMBOSIS 3 0.0021
260 SKIN TOXICITY 12 0.0021
261 CATHETER SITE INFECTION 8 0.0021
262 CHEMOTHERAPY 8 0.0021
263 DUODENAL ULCER HAEMORRHAGE 6 0.0021
264 NEUTROPENIC INFECTION 2 0.0021
265 GASTROINTESTINAL TOXICITY 10 0.0021
266 ENTEROCOLITIS 12 0.0021
267 HAEMOTHORAX 6 0.0021
268 DEVICE RELATED THROMBOSIS 2 0.0020
269 MUCOSAL DISORDER 2 0.0020
270 HIGH DENSITY LIPOPROTEIN INCREASED 2 0.0020
271 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
272 HYPERAMMONAEMIA 10 0.0020
273 ONYCHALGIA 2 0.0020
274 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
275 THROMBOTIC THROMBOCYTOPENIC PURPURA 7 0.0020
276 GASTRIC ULCER HAEMORRHAGE 11 0.0020
277 KERATITIS 6 0.0020
278 NEUTROPENIA 268 0.0020
279 DYSAESTHESIA 6 0.0020
280 PNEUMONIA PSEUDOMONAL 3 0.0020
281 ORAL MUCOSAL ERYTHEMA 3 0.0019
282 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 45 0.0019
283 GASTRIC HAEMORRHAGE 22 0.0019
284 GASTROINTESTINAL STOMA COMPLICATION 3 0.0019
285 METASTASES TO PLEURA 2 0.0019
286 NEUROPATHY PERIPHERAL 177 0.0019
287 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
288 PSEUDOMEMBRANOUS COLITIS 4 0.0018
289 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 2 0.0018
290 MYOCARDIAL INJURY 2 0.0018
291 KLEBSIELLA SEPSIS 2 0.0018
292 HYPERSENSITIVITY PNEUMONITIS 2 0.0018
293 PNEUMONIA BACTERIAL 16 0.0017
294 PERIPHERAL EMBOLISM 2 0.0017
295 PALMAR ERYTHEMA 2 0.0017
296 HAEMOLYTIC URAEMIC SYNDROME 4 0.0017
297 LICHEN PLANUS 4 0.0017
298 DISEASE PROGRESSION 204 0.0017
299 ISCHAEMIC CEREBRAL INFARCTION 2 0.0017
300 NEUROTOXICITY 30 0.0017
301 GENERALISED OEDEMA 21 0.0017
302 ANAL ABSCESS 9 0.0017
303 BILE DUCT STENOSIS 2 0.0017
304 PULMONARY HAEMORRHAGE 13 0.0017
305 PNEUMOMEDIASTINUM 3 0.0017
306 MEAN CELL HAEMOGLOBIN DECREASED 3 0.0016
307 STOMATITIS 99 0.0016
308 METASTASES TO CENTRAL NERVOUS SYSTEM 21 0.0016
309 FISTULA 18 0.0016
310 STENOSIS 3 0.0016
311 GASTRIC ULCER PERFORATION 2 0.0016
312 BONE MARROW FAILURE 32 0.0016
313 SUBARACHNOID HAEMORRHAGE 16 0.0016
314 ADRENAL INSUFFICIENCY 19 0.0016
315 CANCER PAIN 4 0.0016
316 OBSTRUCTION GASTRIC 2 0.0016
317 SKIN EROSION 5 0.0016
318 HYPERBILIRUBINAEMIA 16 0.0015
319 BILIARY OBSTRUCTION 2 0.0015
320 PURULENCE 3 0.0015
321 PLEURAL EFFUSION 93 0.0015
322 OESOPHAGEAL HAEMORRHAGE 2 0.0015
323 CHOLECYSTITIS 18 0.0015
324 CARDIAC FAILURE ACUTE 10 0.0015
325 LARGE INTESTINAL STENOSIS 3 0.0015
326 INTESTINAL DILATATION 2 0.0015
327 WOUND DEHISCENCE 5 0.0015
328 SHOCK HAEMORRHAGIC 12 0.0015
329 HYDRONEPHROSIS 11 0.0015
330 CARBON DIOXIDE INCREASED 2 0.0015
331 VENOUS THROMBOSIS LIMB 3 0.0015
332 SEPTIC SHOCK 63 0.0014
333 BILIARY TRACT DISORDER 2 0.0014
334 SUBILEUS 3 0.0014
335 PNEUMONIA ASPIRATION 36 0.0014
336 INCISIONAL HERNIA 2 0.0014
337 MALNUTRITION 16 0.0014
338 HAEMATEMESIS 36 0.0014
339 PRERENAL FAILURE 2 0.0014
340 NEUTROPHIL COUNT ABNORMAL 4 0.0014
341 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
342 RADIATION PNEUMONITIS 3 0.0014
343 METASTASIS 10 0.0014
344 PELVIC VENOUS THROMBOSIS 2 0.0014
345 HEPATIC CIRRHOSIS 26 0.0014
346 PLATELET COUNT INCREASED 18 0.0014
347 HENOCH-SCHONLEIN PURPURA 3 0.0014
348 ACUTE ABDOMEN 2 0.0014
349 BILIARY DILATATION 2 0.0014
350 PNEUMONIA PNEUMOCOCCAL 2 0.0013
351 EPISTAXIS 101 0.0013
352 APRAXIA 2 0.0013
353 BLOOD LOSS ANAEMIA 3 0.0013
354 MYOGLOBIN BLOOD INCREASED 2 0.0013
355 CALCULUS URINARY 2 0.0013
356 PNEUMOCYSTIS JIROVECII PNEUMONIA 13 0.0013
357 BLOOD ALBUMIN DECREASED 10 0.0013
358 AZOTAEMIA 5 0.0013
359 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
360 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
361 VENTRICULAR HYPOKINESIA 4 0.0012
362 LIVER ABSCESS 4 0.0012
363 SUDDEN DEATH 13 0.0012
364 HEPATIC FAILURE 37 0.0012
365 ORGANISING PNEUMONIA 6 0.0012
366 BLOOD ALKALINE PHOSPHATASE INCREASED 30 0.0012
367 IGA NEPHROPATHY 2 0.0012
368 CEREBRAL HAEMORRHAGE 43 0.0012
369 OEDEMA 65 0.0012
370 PEMPHIGOID 9 0.0012
371 RETINAL ARTERY OCCLUSION 3 0.0012
372 METASTASES TO LYMPH NODES 8 0.0012
373 HEPATORENAL SYNDROME 2 0.0012
374 AGRANULOCYTOSIS 22 0.0012
375 CEREBELLAR INFARCTION 2 0.0012
376 HYPERPYREXIA 5 0.0012
377 APPENDICITIS PERFORATED 3 0.0012
378 PLEURISY 7 0.0012
379 FEMALE GENITAL TRACT FISTULA 2 0.0012
380 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
381 ANAPHYLACTIC SHOCK 30 0.0012
382 BLOOD CHLORIDE DECREASED 3 0.0012
383 C-REACTIVE PROTEIN INCREASED 42 0.0012
384 HEPATIC FUNCTION ABNORMAL 43 0.0012
385 NEOPLASM PROGRESSION 40 0.0011
386 LUNG OPACITY 3 0.0011
387 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25 0.0011
388 HYPOTHYROIDISM 36 0.0011
389 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
390 PLATELET COUNT DECREASED 118 0.0011
391 LARGE INTESTINAL ULCER 3 0.0011
392 AMYLASE INCREASED 4 0.0011
393 CARDIAC DYSFUNCTION 4 0.0011
394 LEUKOENCEPHALOPATHY 4 0.0011
395 MACULAR OEDEMA 6 0.0011
396 UPPER GASTROINTESTINAL HAEMORRHAGE 18 0.0011
397 PSYCHOMOTOR RETARDATION 3 0.0011
398 PROTEIN TOTAL DECREASED 4 0.0011
399 HEPATIC NECROSIS 4 0.0011
400 BILE DUCT OBSTRUCTION 2 0.0011
401 PNEUMATOSIS INTESTINALIS 3 0.0011
402 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
403 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
404 LUNG CANCER METASTATIC 3 0.0010
405 HYPOGLYCAEMIC COMA 3 0.0010
406 STAPHYLOCOCCAL SEPSIS 5 0.0010
407 DECREASED APPETITE 234 0.0010
408 ODYNOPHAGIA 6 0.0010
409 TYPE 1 DIABETES MELLITUS 6 0.0010
410 VARICES OESOPHAGEAL 3 0.0010
411 THROMBOCYTOPENIA 110 0.0010
412 INFUSION RELATED REACTION 65 0.0010
413 AMMONIA INCREASED 5 0.0010
414 NEUTROPHIL COUNT INCREASED 10 0.0010
415 FEMORAL NECK FRACTURE 5 0.0010
416 PORTAL HYPERTENSION 3 0.0010
417 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
418 ERYTHEMA MULTIFORME 9 0.0010
419 BLOOD CREATININE DECREASED 3 0.0010
420 NON-CARDIAC CHEST PAIN 3 0.0009
421 LEUKOPENIA 47 0.0009
422 SPLENOMEGALY 11 0.0009
423 HEPATIC PAIN 4 0.0009
424 OSTEONECROSIS OF JAW 23 0.0009
425 EXPOSED BONE IN JAW 2 0.0009
426 HYPERTENSION 194 0.0009
427 WHITE BLOOD CELL COUNT DECREASED 99 0.0009
428 INTESTINAL ISCHAEMIA 5 0.0009
429 DEEP VEIN THROMBOSIS 59 0.0009
430 BLOOD UREA INCREASED 15 0.0009
431 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
432 LARGE INTESTINAL OBSTRUCTION 2 0.0009
433 BLOOD BILIRUBIN INCREASED 24 0.0009
434 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
435 CHOLECYSTITIS ACUTE 5 0.0009
436 ALANINE AMINOTRANSFERASE INCREASED 54 0.0009
437 ENCEPHALITIS 6 0.0009
438 PULMONARY EMBOLISM 82 0.0009
439 CEREBRAL INFARCTION 21 0.0009
440 DECUBITUS ULCER 7 0.0009
441 BILIRUBIN CONJUGATED INCREASED 2 0.0009
442 ANAEMIA 163 0.0009
443 FIBRIN D DIMER INCREASED 3 0.0008
444 GASTRIC ULCER 16 0.0008
445 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
446 BONE LESION 3 0.0008
447 GASTROINTESTINAL OBSTRUCTION 2 0.0008
448 GASTROINTESTINAL HAEMORRHAGE 69 0.0008
449 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
450 GLOMERULONEPHRITIS 2 0.0008
451 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
452 HYPERTENSIVE CRISIS 9 0.0008
453 NEURODERMATITIS 3 0.0008
454 INFUSION SITE EXTRAVASATION 5 0.0008
455 GENERAL PHYSICAL HEALTH DETERIORATION 92 0.0008
456 FRACTURE 15 0.0008
457 METASTASES TO BONE 13 0.0008
458 COLITIS 30 0.0008
459 DERMATOMYOSITIS 2 0.0008
460 CARDIOTOXICITY 7 0.0008
461 HYPOPHAGIA 20 0.0008
462 OESOPHAGEAL ULCER 3 0.0008
463 CARDIAC FAILURE 62 0.0008
464 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
465 FOLLICULITIS 8 0.0008
466 MYELODYSPLASTIC SYNDROME 11 0.0008
467 SEPSIS 84 0.0008
468 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
469 CYSTITIS HAEMORRHAGIC 3 0.0007
470 GINGIVITIS 4 0.0007
471 BRADYPNOEA 2 0.0007
472 COLITIS ISCHAEMIC 5 0.0007
473 POSTOPERATIVE WOUND INFECTION 5 0.0007
474 LYMPHOCYTE COUNT DECREASED 13 0.0007
475 CYTOPENIA 9 0.0007
476 GINGIVAL BLEEDING 10 0.0007
477 HICCUPS 6 0.0007
478 ASPIRATION 8 0.0007
479 HYPERURICAEMIA 3 0.0007
480 CONGESTIVE CARDIOMYOPATHY 3 0.0007
481 ASPARTATE AMINOTRANSFERASE INCREASED 38 0.0007
482 DEATH 614 0.0007
483 GASTRIC CANCER 18 0.0007
484 PAPULE 5 0.0007
485 DUODENAL ULCER 5 0.0007
486 LIP OEDEMA 3 0.0007
487 IMMUNE THROMBOCYTOPENIC PURPURA 2 0.0007
488 JAUNDICE 19 0.0007
489 ABSCESS LIMB 3 0.0007
490 CARDIAC FAILURE CHRONIC 3 0.0007
491 DRUG-INDUCED LIVER INJURY 22 0.0007
492 METASTATIC NEOPLASM 3 0.0007
493 MONOPLEGIA 3 0.0007
494 SKIN DISORDER 23 0.0007
495 ABSCESS 11 0.0007
496 HYPERTRIGLYCERIDAEMIA 4 0.0007
497 MOUTH HAEMORRHAGE 5 0.0007
498 TUMOUR LYSIS SYNDROME 6 0.0007
499 PURPURA 6 0.0007
500 HAEMOGLOBIN DECREASED 68 0.0007
501 BONE MARROW DISORDER 2 0.0007
502 VASCULAR DEVICE INFECTION 3 0.0007
503 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
504 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
505 RESPIRATORY FAILURE 48 0.0007
506 HYPERTHERMIA 5 0.0007
507 ISCHAEMIA 3 0.0007
508 ANAPHYLACTIC REACTION 36 0.0007
509 DIVERTICULITIS 18 0.0006
510 LOCALISED OEDEMA 3 0.0006
511 APHTHOUS ULCER 5 0.0006
512 HYPONATRAEMIA 36 0.0006
513 COLITIS MICROSCOPIC 3 0.0006
514 BILE DUCT STONE 2 0.0006
515 ENTERITIS 4 0.0006
516 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
517 HAEMATURIA 21 0.0006
518 HAEMATOCRIT DECREASED 12 0.0006
519 CORONAVIRUS INFECTION 4 0.0006
520 IMMUNODEFICIENCY 9 0.0006
521 ELECTROLYTE IMBALANCE 7 0.0006
522 HEMIPLEGIA 5 0.0006
523 VASCULITIS 7 0.0006
524 NEPHRITIS 2 0.0006
525 PERITONITIS BACTERIAL 6 0.0006
526 FACE OEDEMA 10 0.0006
527 ULCER HAEMORRHAGE 4 0.0006
528 MELAENA 13 0.0006
529 BACTERAEMIA 7 0.0006
530 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
531 VARICOSE VEIN 3 0.0006
532 SKIN NECROSIS 3 0.0006
533 FAILURE TO THRIVE 3 0.0006
534 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
535 OEDEMA PERIPHERAL 70 0.0006
536 LUNG DISORDER 28 0.0006
537 SMALL INTESTINAL OBSTRUCTION 7 0.0006
538 NECROTISING FASCIITIS 2 0.0006
539 IMMUNOSUPPRESSION 5 0.0006
540 DRUG ERUPTION 10 0.0006
541 LIVER DISORDER 25 0.0006
542 PERICARDIAL EFFUSION 13 0.0006
543 ANAL FISTULA 3 0.0006
544 LUNG NEOPLASM MALIGNANT 23 0.0006
545 ABDOMINAL PAIN 129 0.0006
546 PYREXIA 191 0.0006
547 HYDROCEPHALUS 3 0.0006
548 RASH PUSTULAR 4 0.0005
549 CUTANEOUS VASCULITIS 2 0.0005
550 DISEASE RECURRENCE 26 0.0005
551 TASTE DISORDER 11 0.0005
552 UROSEPSIS 5 0.0005
553 HYPERKALAEMIA 19 0.0005
554 STREPTOCOCCAL INFECTION 3 0.0005
555 INTRACRANIAL PRESSURE INCREASED 3 0.0005
556 BLOOD CALCIUM DECREASED 6 0.0005
557 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
558 INTESTINAL OBSTRUCTION 20 0.0005
559 MITRAL VALVE INCOMPETENCE 6 0.0005
560 CIRCULATORY COLLAPSE 9 0.0005
561 GRANULOCYTOPENIA 3 0.0005
562 COMMUNICATION DISORDER 2 0.0005
563 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
564 HYPOKALAEMIA 24 0.0005
565 IMPAIRED HEALING 17 0.0005
566 LUNG INFECTION 8 0.0005
567 HYPOXIA 18 0.0005
568 DRUG RESISTANCE 13 0.0005
569 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
570 DYSPHAGIA 48 0.0005
571 PNEUMONIA 163 0.0005
572 OBSTRUCTION 2 0.0005
573 MUSCLE HAEMORRHAGE 2 0.0005
574 HAEMORRHAGE 52 0.0005
575 FEEDING DISORDER 10 0.0005
576 PERIPHERAL ISCHAEMIA 2 0.0005
577 ACUTE CORONARY SYNDROME 4 0.0005
578 ONYCHOMADESIS 2 0.0005
579 LUNG NEOPLASM 2 0.0005
580 BONE CANCER 2 0.0005
581 ORAL CANDIDIASIS 6 0.0005
582 HAEMORRHAGIC ANAEMIA 2 0.0005
583 DEVICE RELATED INFECTION 7 0.0005
584 RED BLOOD CELL COUNT DECREASED 13 0.0005
585 GINGIVAL SWELLING 2 0.0005
586 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
587 RESPIRATORY RATE INCREASED 4 0.0005
588 EJECTION FRACTION DECREASED 7 0.0004
589 THROMBOSIS 36 0.0004
590 NEPHROPATHY TOXIC 5 0.0004
591 RECTAL HAEMORRHAGE 19 0.0004
592 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
593 RENAL IMPAIRMENT 37 0.0004
594 IMMUNE THROMBOCYTOPENIA 2 0.0004
595 LYMPHOEDEMA 3 0.0004
596 NEPHROPATHY 4 0.0004
597 APPENDICITIS 4 0.0004
598 FLANK PAIN 4 0.0004
599 DYSPNOEA EXERTIONAL 16 0.0004
600 BLOOD SODIUM DECREASED 8 0.0004
601 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
602 RETINAL HAEMORRHAGE 3 0.0004
603 CARDIAC TAMPONADE 2 0.0004
604 ACUTE RESPIRATORY FAILURE 8 0.0004
605 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
606 ORAL DISORDER 3 0.0004
607 CARDIOMYOPATHY 6 0.0004
608 HYPOPHOSPHATAEMIA 3 0.0004
609 HOSPICE CARE 4 0.0004
610 DEHYDRATION 54 0.0004
611 STEVENS-JOHNSON SYNDROME 9 0.0004
612 HYPERVOLAEMIA 2 0.0004
613 INFLAMMATORY MARKER INCREASED 2 0.0004
614 ABDOMINAL TENDERNESS 2 0.0004
615 HAEMORRHAGE INTRACRANIAL 6 0.0004
616 LACRIMATION INCREASED 12 0.0004
617 BRAIN OEDEMA 5 0.0004
618 HEPATOCELLULAR CARCINOMA 3 0.0004
619 TOOTH ABSCESS 4 0.0004
620 LIPASE INCREASED 3 0.0004
621 SHOCK 9 0.0004
622 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
623 THYROID DISORDER 6 0.0004
624 HAEMOLYSIS 3 0.0004
625 ACUTE KIDNEY INJURY 59 0.0004
626 BLOOD LACTIC ACID INCREASED 2 0.0004
627 FULL BLOOD COUNT ABNORMAL 4 0.0004
628 ATRIAL FLUTTER 3 0.0004
629 EATING DISORDER 8 0.0004
630 HEPATIC CANCER 9 0.0004
631 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
632 CHEILITIS 2 0.0004
633 BLOOD POTASSIUM DECREASED 11 0.0004
634 MENTAL STATUS CHANGES 10 0.0004
635 EOSINOPHIL COUNT INCREASED 3 0.0004
636 NECROSIS 2 0.0004
637 INFECTION 52 0.0004
638 PERICARDITIS 6 0.0004
639 SKIN INFECTION 4 0.0004
640 DIARRHOEA 229 0.0004
641 HEMIPARESIS 6 0.0004
642 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
643 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
644 GENERALISED ERYTHEMA 2 0.0004
645 PRESCRIBED UNDERDOSE 7 0.0004
646 INTERNAL HAEMORRHAGE 4 0.0003
647 SKIN HYPERPIGMENTATION 3 0.0003
648 ANURIA 3 0.0003
649 EXERCISE TOLERANCE DECREASED 2 0.0003
650 PYELONEPHRITIS 3 0.0003
651 DELIRIUM 12 0.0003
652 PANCYTOPENIA 19 0.0003
653 CARDIAC FAILURE CONGESTIVE 27 0.0003
654 HAEMOLYTIC ANAEMIA 3 0.0003
655 MYOSITIS 3 0.0003
656 DERMATITIS 7 0.0003
657 OSTEOMYELITIS 6 0.0003
658 PALLOR 9 0.0003
659 URINARY RETENTION 11 0.0003
660 INGUINAL HERNIA 2 0.0003
661 RETINAL DETACHMENT 3 0.0003
662 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
663 IRON DEFICIENCY ANAEMIA 3 0.0003
664 DYSPHONIA 19 0.0003
665 OLIGURIA 2 0.0003
666 NERVOUS SYSTEM DISORDER 10 0.0003
667 INFUSION SITE SWELLING 2 0.0003
668 HYPOCALCAEMIA 6 0.0003
669 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
670 LYMPHADENOPATHY 11 0.0003
671 UNRESPONSIVE TO STIMULI 8 0.0003
672 HEPATITIS ACUTE 2 0.0003
673 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
674 WEIGHT DECREASED 85 0.0003
675 GASTRITIS 8 0.0003
676 IMMUNE SYSTEM DISORDER 4 0.0003
677 RESPIRATORY DISORDER 9 0.0003
678 HYPOAESTHESIA 45 0.0003
679 RENAL DISORDER 14 0.0003
680 BRAIN INJURY 3 0.0003
681 MALAISE 131 0.0003
682 VOMITING 140 0.0003
683 PAIN OF SKIN 8 0.0003
684 ABDOMINAL DISTENSION 31 0.0003
685 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
686 MOTOR DYSFUNCTION 3 0.0003
687 PRODUCTIVE COUGH 14 0.0003
688 ONYCHOCLASIS 2 0.0003
689 BONE PAIN 17 0.0003
690 HYPERTRANSAMINASAEMIA 2 0.0003
691 AUTOIMMUNE HEPATITIS 2 0.0003
692 ATRIAL FIBRILLATION 28 0.0003
693 PETECHIAE 3 0.0003
694 HYPOMAGNESAEMIA 4 0.0003
695 DEFAECATION URGENCY 2 0.0003
696 ALOPECIA 56 0.0003
697 BRONCHOSPASM 4 0.0003
698 LIVER FUNCTION TEST INCREASED 6 0.0003
699 SUBDURAL HAEMATOMA 4 0.0003
700 DECREASED ACTIVITY 3 0.0003
701 CONSTIPATION 60 0.0003
702 OESOPHAGITIS 3 0.0003
703 HEPATITIS 7 0.0003
704 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
705 TRANSAMINASES INCREASED 6 0.0003
706 DUODENAL ULCER PERFORATION 2 0.0003
707 COLON CANCER 4 0.0003
708 GLOSSODYNIA 6 0.0003
709 OXYGEN SATURATION DECREASED 15 0.0003
710 DYSARTHRIA 10 0.0003
711 NAUSEA 209 0.0003
712 MYOCARDIAL ISCHAEMIA 3 0.0003
713 ASTHENIA 99 0.0003
714 HAEMODYNAMIC INSTABILITY 2 0.0003
715 MYOCARDITIS 3 0.0003
716 EPILEPSY 8 0.0003
717 SKIN EXFOLIATION 22 0.0003
718 FATIGUE 203 0.0003
719 UNINTENTIONAL MEDICAL DEVICE REMOVAL 3 0.0003
720 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
721 HAEMORRHOIDS 5 0.0003
722 GASTROINTESTINAL INFLAMMATION 2 0.0003
723 CYANOSIS 4 0.0003
724 COVID-19 PNEUMONIA 3 0.0003
725 HAEMATOCHEZIA 14 0.0003
726 TREATMENT FAILURE 21 0.0003
727 GINGIVAL PAIN 2 0.0003
728 DEMENTIA 7 0.0003
729 OFF LABEL USE 218 0.0002
730 ERYTHEMA 51 0.0002
731 HYPERSENSITIVITY 46 0.0002
732 ABDOMINAL PAIN UPPER 51 0.0002
733 PRODUCT USE IN UNAPPROVED INDICATION 61 0.0002
734 ENCEPHALOPATHY 6 0.0002
735 ESCHERICHIA INFECTION 2 0.0002
736 HYPERCALCAEMIA 3 0.0002
737 VENTRICULAR TACHYCARDIA 4 0.0002
738 BLOOD PRESSURE INCREASED 37 0.0002
739 DRUG LEVEL INCREASED 4 0.0002
740 DYSPNOEA 134 0.0002
741 RETCHING 5 0.0002
742 PRURITUS GENERALISED 5 0.0002
743 BLOOD CREATININE INCREASED 15 0.0002
744 ORTHOSTATIC HYPOTENSION 4 0.0002
745 APPLICATION SITE ERYTHEMA 6 0.0002
746 NAIL DISORDER 2 0.0002
747 DRUG INTOLERANCE 22 0.0002
748 SARS-COV-2 TEST POSITIVE 3 0.0002
749 DISORIENTATION 9 0.0002
750 BLOOD PRESSURE DECREASED 15 0.0002
751 TACHYCARDIA 20 0.0002
752 HEPATOTOXICITY 5 0.0002
753 ISCHAEMIC STROKE 4 0.0002
754 MALIGNANT MELANOMA 3 0.0002
755 PULMONARY OEDEMA 10 0.0002
756 PANCREATITIS ACUTE 5 0.0002
757 OROPHARYNGEAL DISCOMFORT 2 0.0002
758 LEUKOCYTOSIS 4 0.0002
759 PELVIC PAIN 4 0.0002
760 ACUTE HEPATIC FAILURE 3 0.0002
761 CELLULITIS 11 0.0002
762 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
763 CHEST PAIN 40 0.0002
764 RHABDOMYOLYSIS 9 0.0002
765 CONJUNCTIVITIS 4 0.0002
766 WOUND 6 0.0002
767 DIARRHOEA HAEMORRHAGIC 2 0.0002
768 SINUS TACHYCARDIA 3 0.0002
769 SYNCOPE 21 0.0002
770 CHOLESTASIS 4 0.0002
771 DIABETIC KETOACIDOSIS 5 0.0002
772 ATELECTASIS 2 0.0002
773 INFLAMMATORY BOWEL DISEASE 2 0.0002
774 ACUTE MYOCARDIAL INFARCTION 6 0.0002
775 URTICARIA 34 0.0002
776 GASTROINTESTINAL DISORDER 18 0.0002
777 FULL BLOOD COUNT DECREASED 4 0.0002
778 HYPOTHERMIA 2 0.0002
779 FLUSHING 20 0.0002
780 RENAL FAILURE 26 0.0002
781 PHARYNGEAL OEDEMA 3 0.0002
782 RASH 85 0.0002
783 EAR DISCOMFORT 2 0.0002
784 RIB FRACTURE 4 0.0002
785 SKIN ULCER 5 0.0002
786 DIPLOPIA 5 0.0002
787 PULMONARY HYPERTENSION 4 0.0002
788 RESPIRATORY TRACT INFECTION 5 0.0002
789 MOUTH ULCERATION 4 0.0002
790 HYPOTENSION 38 0.0002
791 PANCREATITIS 10 0.0002
792 DRUG INTERACTION 30 0.0002
793 LOSS OF CONSCIOUSNESS 24 0.0002
794 COUGH 52 0.0002
795 FAECES DISCOLOURED 4 0.0002
796 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
797 STAPHYLOCOCCAL INFECTION 6 0.0002
798 COAGULOPATHY 3 0.0002
799 RASH MACULO-PAPULAR 4 0.0002
800 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
801 ORAL PAIN 4 0.0002
802 BLISTER 10 0.0002
803 SEIZURE 20 0.0002
804 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
805 MADAROSIS 2 0.0002
806 EYELID OEDEMA 2 0.0002
807 POST PROCEDURAL HAEMORRHAGE 2 0.0002
808 PARAESTHESIA 27 0.0002
809 COGNITIVE DISORDER 8 0.0002
810 CEREBROVASCULAR ACCIDENT 29 0.0002
811 CHILLS 20 0.0002
812 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
813 CARDIAC ARREST 14 0.0002
814 BACK PAIN 39 0.0002
815 MYOCLONUS 2 0.0002
816 CARDIO-RESPIRATORY ARREST 7 0.0002
817 HYPERLIPIDAEMIA 2 0.0002
818 HYPERGLYCAEMIA 6 0.0002
819 DYSURIA 6 0.0002
820 LIVER INJURY 4 0.0002
821 CARDIOMEGALY 2 0.0002
822 FEMUR FRACTURE 5 0.0002
823 PRURITUS 62 0.0002
824 URINARY TRACT INFECTION 27 0.0002
825 CHEST DISCOMFORT 16 0.0002
826 THERAPY NON-RESPONDER 7 0.0002
827 INFUSION SITE PAIN 2 0.0002
828 PRESCRIBED OVERDOSE 3 0.0002
829 RASH GENERALISED 4 0.0002
830 COVID-19 27 0.0002
831 DEAFNESS 4 0.0002
832 OSTEONECROSIS 5 0.0002
833 BRADYCARDIA 8 0.0002
834 LIP SWELLING 5 0.0001
835 SPINAL FRACTURE 3 0.0001
836 THERAPEUTIC RESPONSE DECREASED 9 0.0001
837 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
838 DYSGEUSIA 11 0.0001
839 ARRHYTHMIA 7 0.0001
840 DISCOMFORT 9 0.0001
841 SKIN LESION 4 0.0001
842 BLINDNESS UNILATERAL 2 0.0001
843 CARDIOGENIC SHOCK 2 0.0001
844 SWELLING FACE 9 0.0001
845 HYPOKINESIA 2 0.0001
846 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
847 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
848 TOXICITY TO VARIOUS AGENTS 23 0.0001
849 OESOPHAGEAL CARCINOMA 4 0.0001
850 THROAT IRRITATION 6 0.0001
851 HYPOAESTHESIA ORAL 2 0.0001
852 APHASIA 4 0.0001
853 HYPERHIDROSIS 17 0.0001
854 CONDITION AGGRAVATED 40 0.0001
855 TINNITUS 6 0.0001
856 SKIN DISCOLOURATION 6 0.0001
857 DRUG INEFFECTIVE 172 0.0001
858 DEVICE ADHESION ISSUE 2 0.0001
859 MUSCULOSKELETAL CHEST PAIN 2 0.0001
860 ACUTE MYELOID LEUKAEMIA 2 0.0001
861 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
862 MEDICATION ERROR 7 0.0001
863 HYPOGLYCAEMIA 6 0.0001
864 PRESYNCOPE 3 0.0001
865 FALL 41 0.0001
866 ADVERSE DRUG REACTION 11 0.0001
867 PHOTOSENSITIVITY REACTION 2 0.0001
868 ABDOMINAL PAIN LOWER 3 0.0001
869 CANDIDA INFECTION 2 0.0001
870 HEPATIC ENZYME INCREASED 8 0.0001
871 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
872 INFLAMMATION 6 0.0001
873 HAEMATOMA 3 0.0001
874 MULTI-ORGAN FAILURE 2 0.0001
875 MUSCULOSKELETAL PAIN 6 0.0001
876 SPEECH DISORDER 6 0.0001
877 ANGIOEDEMA 5 0.0001
878 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
879 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
880 THROAT TIGHTNESS 3 0.0001
881 MYOCARDIAL INFARCTION 19 0.0001
882 RESPIRATORY ARREST 3 0.0001
883 RESPIRATORY DISTRESS 3 0.0001
884 BLOOD GLUCOSE ABNORMAL 2 0.0001
885 HEPATIC STEATOSIS 2 0.0001
886 BACTERIAL INFECTION 2 0.0001
887 MYALGIA 18 0.0001
888 MUSCULAR WEAKNESS 12 0.0001
889 BLOOD URINE PRESENT 2 0.0001
890 RASH ERYTHEMATOUS 5 0.0001
891 LETHARGY 6 0.0001
892 POST PROCEDURAL COMPLICATION 2 0.0001
893 HERNIA 2 0.0001
894 LIVER FUNCTION TEST ABNORMAL 3 0.0001
895 LABORATORY TEST ABNORMAL 3 0.0001
896 CORONARY ARTERY DISEASE 3 0.0001
897 DYSKINESIA 4 0.0001
898 FLUID RETENTION 5 0.0001
899 FEELING HOT 6 0.0001
900 PERIPHERAL SWELLING 15 0.0001
901 ECZEMA 5 0.0001
902 HIP FRACTURE 3 0.0001
903 RASH PRURITIC 5 0.0001
904 VAGINAL HAEMORRHAGE 4 0.0001
905 PRODUCT PRESCRIBING ISSUE 2 0.0001
906 CHOLELITHIASIS 3 0.0001
907 PAIN 56 0.0001
908 HEART RATE IRREGULAR 2 0.0001
909 OROPHARYNGEAL PAIN 8 0.0001
910 BURNING SENSATION 6 0.0001
911 SWELLING 8 0.0001
912 HEART RATE DECREASED 3 0.0001
913 BLOOD GLUCOSE INCREASED 16 0.0001
914 MOBILITY DECREASED 6 0.0001
915 BLOOD GLUCOSE DECREASED 4 0.0001
916 UNDERDOSE 6 0.0001
917 ABASIA 2 0.0001
918 CONFUSIONAL STATE 13 0.0001
919 GAIT DISTURBANCE 15 0.0001
920 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
921 SOMNOLENCE 15 0.0001
922 LIMB INJURY 2 0.0001
923 CONTUSION 7 0.0001
924 ROAD TRAFFIC ACCIDENT 3 0.0001
925 ABDOMINAL DISCOMFORT 12 0.0001
926 DYSPEPSIA 7 0.0001
927 OSTEOARTHRITIS 3 0.0001
928 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
929 ANGINA PECTORIS 2 0.0001
930 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
931 MENTAL DISORDER 3 0.0001
932 HEADACHE 42 0.0001
933 VERTIGO 4 0.0001
934 ADVERSE EVENT 6 0.0001
935 HEAD INJURY 2 0.0001
936 COMA 3 0.0001
937 INFLUENZA 7 0.0001
938 METABOLIC ACIDOSIS 2 0.0001
939 LACTIC ACIDOSIS 2 0.0001
940 AMNESIA 4 0.0001
941 PAIN IN EXTREMITY 18 0.0001
942 HEART RATE INCREASED 6 0.0001
943 EXPIRED PRODUCT ADMINISTERED 2 0.0001
944 MUSCLE SPASMS 11 0.0001
945 GASTRIC DISORDER 2 0.0001
946 WEIGHT INCREASED 13 0.0001
947 DEVICE USE ERROR 2 0.0001
948 HALLUCINATION 4 0.0001
949 ACNE 4 0.0001
950 DRY SKIN 7 0.0001
951 HERPES ZOSTER 3 0.0001
952 EYE IRRITATION 3 0.0001
953 HOSPITALISATION 8 0.0001
954 WHEEZING 3 0.0001
955 ABNORMAL BEHAVIOUR 2 0.0001
956 DRY MOUTH 4 0.0000
957 PSORIATIC ARTHROPATHY 2 0.0000
958 VISUAL IMPAIRMENT 6 0.0000
959 HYPOACUSIS 2 0.0000
960 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
961 PRODUCT USE ISSUE 8 0.0000
962 INSOMNIA 11 0.0000
963 ARTHRALGIA 17 0.0000
964 DRY EYE 2 0.0000
965 ILLNESS 4 0.0000
966 ARTHRITIS 3 0.0000
967 DIZZINESS 19 0.0000
968 DEPRESSED MOOD 2 0.0000
969 DRUG EFFECT DECREASED 2 0.0000
970 DISTURBANCE IN ATTENTION 2 0.0000
971 VISION BLURRED 5 0.0000
972 TREMOR 6 0.0000
973 PALPITATIONS 4 0.0000
974 ILL-DEFINED DISORDER 2 0.0000
975 PSORIASIS 4 0.0000
976 NEOPLASM MALIGNANT 2 0.0000
977 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
978 ANXIETY 8 0.0000
979 OVERDOSE 6 0.0000
980 ASTHMA 3 0.0000
981 FEELING ABNORMAL 6 0.0000
982 PROSTATE CANCER 2 0.0000
983 JOINT SWELLING 3 0.0000
984 INFLUENZA LIKE ILLNESS 2 0.0000
985 DRUG DOSE OMISSION 4 0.0000
986 DRUG ABUSE 2 0.0000
987 INTENTIONAL PRODUCT MISUSE 2 0.0000
988 DEPRESSION 5 0.0000
989 MEMORY IMPAIRMENT 3 0.0000
990 CARDIAC DISORDER 2 0.0000
991 NASOPHARYNGITIS 3 0.0000
992 NO ADVERSE EVENT 2 0.0000
993 PRODUCT DOSE OMISSION ISSUE 2 0.0000